Loracarbef (LY163892) versus amoxicillin-calvulanate in the treatment of bacterial acute otitis media with effusion
- 30 June 1992
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 120 (6) , 980-986
- https://doi.org/10.1016/s0022-3476(05)81974-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Comparative reactivity of 1-carba-1-dethiacephalosporins with cephalosporinsJournal of Medicinal Chemistry, 1990
- 3-Sulfonyl-1-carba-1-dethiacephemsJournal of Medicinal Chemistry, 1989
- Cost effectiveness of antibiotic therapy for otitis media in a military pediatric clinicThe Pediatric Infectious Disease Journal, 1988
- In vitro susceptibilities of common pediatric pathogens to LY163892Antimicrobial Agents and Chemotherapy, 1988
- In vitro activities of LY163892, cefaclor, and cefuroximeAntimicrobial Agents and Chemotherapy, 1988
- Five vs. ten days of therapy for acute otitis mediaThe Pediatric Infectious Disease Journal, 1988
- Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892European Journal of Clinical Microbiology & Infectious Diseases, 1987
- Amoxicillin-clavulanate potassium compared with cefaclor for acute otitis media in infants and childrenThe Pediatric Infectious Disease Journal, 1987
- Acute Otitis Media in ChildrenAmerican Journal of Diseases of Children, 1966